[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fZBKqlikOqIYXzjJgvwCHbqWhYhlQsqEAeb4C4WQL0r4":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":35,"rows":42},"W.L.Gore & Associates",[4],94,false,38,4,23884,0,92,[14,17,20,23,25,27,29,32],{"name":15,"count":16},"Aortic Aneurysm, Thoracic",7,{"name":18,"count":19},"Peripheral Arterial Disease",6,{"name":21,"count":22},"Peripheral Vascular Diseases",5,{"name":24,"count":9},"Thoracoabdominal Aortic Aneurysm",{"name":26,"count":9},"Thoracic Aortic Aneurysm",{"name":28,"count":9},"Aortic Aneurysm, Abdominal",{"name":30,"count":31},"Abdominal Aortic Aneurysm",3,{"name":33,"count":31},"PFO - Patent Foramen Ovale",[],[36,37,38,39,40,41],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[43,70],{"intervention":44,"totalTrials":45,"cells":46},"Thienopyridine",1,{"EARLY_PHASE1":47,"PHASE1":49,"PHASE2":51,"PHASE3":53,"PHASE4":55,"NA":57},{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[],{"trials":56,"activeCount":11},[],{"trials":58,"activeCount":11},[59],{"nctId":60,"briefTitle":61,"status":62,"phases":63,"primaryCompletion":64,"completion":64,"start":65,"enrollment":16,"conditions":66,"interventions":69},"NCT04100135","GORE® CARDIOFORM Septal Occluder Migraine Clinical Study","TERMINATED",[41],"2024-08-15","2021-02-05",[67,68,33],"Migraine","Patent Foramen Ovale",[44],{"intervention":71,"totalTrials":45,"cells":72},"Antiplatelet Medical Therapy",{"EARLY_PHASE1":73,"PHASE1":75,"PHASE2":77,"PHASE3":79,"PHASE4":81,"NA":83},{"trials":74,"activeCount":11},[],{"trials":76,"activeCount":11},[],{"trials":78,"activeCount":11},[],{"trials":80,"activeCount":11},[],{"trials":82,"activeCount":11},[],{"trials":84,"activeCount":11},[85],{"nctId":86,"briefTitle":87,"status":88,"phases":89,"primaryCompletion":90,"completion":91,"start":92,"enrollment":93,"conditions":94,"interventions":97},"NCT00738894","GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients","COMPLETED",[41],"2017-04-24","2020-05-11","2008-12-10",664,[95,96],"Stroke","Transient Ischemic Attack",[71]]